Medican Financial Statements From 2010 to 2025
| MDCN Stock | USD 0.0001 0.00 0.00% |
Check Medican Enterprises financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medican Enterprises' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medican financial statements analysis is a perfect complement when working with Medican Enterprises Valuation or Volatility modules.
Medican |
Medican Enterprises Company Current Valuation Analysis
Medican Enterprises' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medican Enterprises Current Valuation | 7.77 M |
Most of Medican Enterprises' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medican Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medican Enterprises has a Current Valuation of 7.77 M. This is 99.95% lower than that of the Pharmaceuticals sector and 99.89% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.95% higher than that of the company.
Medican Enterprises Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medican Enterprises's current stock value. Our valuation model uses many indicators to compare Medican Enterprises value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medican Enterprises competition to find correlations between indicators driving Medican Enterprises's intrinsic value. More Info.Medican Enterprises is considered to be number one stock in return on asset category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medican Enterprises by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medican Enterprises' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Medican Enterprises Financial Statements
Medican Enterprises investors utilize fundamental indicators, such as revenue or net income, to predict how Medican Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada. Medican Enterprises operates under Real Estate Services classification in the United States and is traded on OTC Exchange. It employs 3 people.
Pair Trading with Medican Enterprises
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medican Enterprises position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medican Enterprises will appreciate offsetting losses from the drop in the long position's value.Moving against Medican Pink Sheet
| 0.72 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.58 | AA | Alcoa Corp | PairCorr |
| 0.46 | PKX | POSCO Holdings | PairCorr |
| 0.4 | HPQ | HP Inc | PairCorr |
| 0.35 | DIS | Walt Disney | PairCorr |
The ability to find closely correlated positions to Medican Enterprises could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medican Enterprises when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medican Enterprises - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medican Enterprises to buy it.
The correlation of Medican Enterprises is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medican Enterprises moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medican Enterprises moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medican Enterprises can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medican Pink Sheet
Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.